ArticleActa pharmaceutica Sinica. B2022
Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy.
Xianbin Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
48 papers cite it
this paperpooled itcites it
ArticleActa pharmaceutica Sinica. B2022
Xianbin Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.